Phil Hyu Lee Selected Research

Phil Hyu Lee Research Topics

Disease

97	Parkinson Disease (Parkinson's Disease) 04/2024 - 03/2006
35	Dementia (Dementias) 04/2024 - 12/2008
31	Cognitive Dysfunction 04/2024 - 12/2008
29	Dyskinesias (Dyskinesia) 02/2024 - 10/2010
22	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 12/2009
18	Parkinsonian Disorders (Parkinsonism) 01/2023 - 03/2006
13	Multiple System Atrophy 01/2021 - 03/2006
10	Synucleinopathies 10/2021 - 03/2009
7	Atrophy 11/2023 - 01/2014
6	Disease Progression 01/2023 - 07/2011
6	Lewy Body Disease (Lewy Body Dementia) 01/2023 - 01/2020
6	Ischemic Stroke 01/2016 - 06/2005
6	Stroke (Strokes) 06/2010 - 04/2005
5	Cerebral Cortical Thinning 01/2020 - 01/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 03/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2009 - 04/2005
2	Genetic Risk Score 05/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2017
2	Body Weight (Weight, Body) 11/2021 - 01/2021
2	Autonomic Nervous System Diseases (Dysautonomia) 01/2021 - 08/2020
2	Hypertension (High Blood Pressure) 11/2019 - 04/2009
2	Task-Specific Focal Dystonia 01/2019 - 12/2016
2	Emergence Delirium 01/2018 - 02/2013
2	Frontotemporal Dementia (Semantic Dementia) 01/2018 - 12/2009
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2018 - 01/2015
2	Movement Disorders (Movement Disorder) 01/2016 - 05/2015
2	Tremor (Tremors) 11/2013 - 08/2006
2	Gaucher Disease (Gaucher's Disease) 04/2012 - 06/2011
2	Pain (Aches) 03/2012 - 06/2011
2	Neuroblastoma 03/2010 - 06/2006
2	Brain Ischemia (Cerebral Ischemia) 04/2009 - 06/2006
2	Inflammation (Inflammations) 01/2009 - 07/2007
1	Hallucinations (Hallucination) 12/2023
1	Nervous System Diseases (Neurological Disorders) 11/2021
1	Sarcopenia 11/2021
1	Spinal Diseases (Disease, Spinal) 03/2021
1	Hypokinesia (Bradykinesia) 01/2021
1	Anosmia 01/2021
1	Neuroinflammatory Diseases 07/2020
1	Wounds and Injuries (Trauma) 05/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2019

Drug/Important Bio-Agent (IBA)

38	Levodopa (L Dopa)FDA LinkGeneric 04/2024 - 11/2009
32	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 05/2014
22	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 11/2023 - 11/2013
19	Amyloid (Amyloid Fibrils)IBA 01/2024 - 03/2012
15	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
12	SynucleinsIBA 12/2023 - 02/2013
8	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 04/2021 - 10/2018
6	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 06/2024 - 05/2014
6	Neuroprotective AgentsIBA 01/2023 - 11/2009
5	Cholinergic Agents (Cholinergics)IBA 01/2022 - 03/2012
5	Uric Acid (Urate)IBA 10/2021 - 07/2011
4	CholesterolIBA 01/2024 - 04/2009
4	Glucosylceramidase (Glucocerebrosidase)IBA 01/2021 - 06/2011
4	alpha-SynucleinIBA 01/2018 - 03/2009
4	3-Iodobenzylguanidine (Iobenguane)IBA 11/2007 - 03/2006
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 04/2024 - 01/2011
3	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 05/2023 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2006
3	HomocysteineIBA 10/2014 - 03/2010
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2017
2	Apolipoprotein E4IBA 10/2021 - 10/2021
2	Memantine (Namenda)FDA Link 10/2021 - 05/2015
2	Apolipoproteins E (ApoE)IBA 10/2021 - 01/2013
2	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 01/2015
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2014 - 11/2009
2	AcidsIBA 07/2014 - 09/2009
2	C-Reactive ProteinIBA 02/2009 - 04/2005
2	LipopolysaccharidesIBA 01/2009 - 07/2007
1	Dopa DecarboxylaseIBA 04/2024
1	opicaponeIBA 04/2024
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 12/2023
1	Cholinergic Antagonists (Anticholinergics)IBA 09/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	DihydropyridinesIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	AntioxidantsIBA 10/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	Donepezil (Aricept)FDA LinkGeneric 01/2021
1	valrubicin (AD 32)FDA Link 01/2021
1	Therapeutic UsesIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2019

Therapy/Procedure

12	Therapeutics 04/2024 - 06/2005
4	Transplantation 01/2015 - 06/2005
3	Deep Brain Stimulation 12/2023 - 10/2010
3	Mesenchymal Stem Cell Transplantation 06/2010 - 06/2005
2	Denervation 10/2022 - 11/2014
2	Secondary Prevention 11/2021 - 02/2008
2	Gastrectomy 01/2019 - 02/2013
2	Activities of Daily Living (ADL) 01/2017 - 03/2012
1	Postoperative Care 03/2021